Antiosteoporotic effect of orally administered yolk-derived peptides on bone mass in women.

As shown in Figure 2 B and Table 2 , subjects receiving HYP (WA-3 group) showed a trend of increasing BAP levels, compared to other subjects at third month of examination, however, unexpectedly at sixth month BAP gave reduced levels compared to WA-1 group.

also in 53,322 other papers

As shown in Figure 3 B, and Table 3 , only WA-3 group showed a decreasing trend of NTx level compared to the other two groups, however, there were no significant differences observed in NTx levels among all groups.

also in 47,180 other papers